Head-to-head · WeighScore
Ivim Health vs NP2GO
By GLP-1 ScorecardUpdated
Score comparison
NP2GO has the higher recorded score — 80.2/100 to 59.6/100.
NP2GO grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Both molecules across 40 states, but upper-mid pricing and no verification listing.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Ivim Health | NP2GO |
|---|---|---|
| WeighScore | 59.6/100 | 80.2/100 |
| Grade | C | B− |
| Site position | #385 | #37 |
| Semaglutide | $149/mo (starting dose, medication and program fee, compounded) | $150/mo |
| Tirzepatide | $224/mo (starting dose, medication and program fee, compounded) | $250/mo |
| Coverage | Coverage not published | 40 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #385 · C
Strengths
- Both molecules are priced on one page, each quoted as medication and program charge included rather than as a bare drug price
- A six-month commitment brings tirzepatide down to $133/mo, and the term is published rather than hidden
- The first month of the membership is free
What to consider
- A $75/mo membership is marketed as a separate product, and whether it is charged on top of the $149 medication rate is not stated anywhere we could find
- The $133/mo tirzepatide rate advertised on the homepage requires a six-month commitment; the month-to-month rate is $224
- Both figures are 'starting at' rates, so the cost of a titrated dose is not published
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Site position #37 · B−
Strengths
- Both molecules
- 40-state footprint
- Transparent listed pricing
What to consider
- Independent LegitScript certification has not been verified for this review
- Upper-mid pricing ($150/$250)
- Not all 50 states
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.